Empowered Funds LLC Acquires New Position in Ralliant Corporation $RAL

Empowered Funds LLC bought a new position in shares of Ralliant Corporation (NYSE:RAL) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 112,205 shares of the company’s stock, valued at approximately $8,262,000. Empowered Funds LLC owned 0.10% of Ralliant as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Ralliant in the second quarter valued at $1,039,481,000. Viking Global Investors LP purchased a new stake in Ralliant during the 2nd quarter worth about $257,200,000. State Street Corp acquired a new stake in Ralliant in the 2nd quarter valued at about $213,096,000. Millennium Management LLC raised its position in Ralliant by 172.4% in the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock valued at $253,175,000 after purchasing an additional 3,147,660 shares in the last quarter. Finally, Flossbach Von Storch SE purchased a new position in shares of Ralliant in the 2nd quarter valued at about $222,460,000.

Insider Activity

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by corporate insiders.

Ralliant Price Performance

Shares of NYSE RAL opened at $61.65 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. The stock has a market cap of $6.82 billion, a P/E ratio of -5.68, a P/E/G ratio of 2.29 and a beta of 1.60. The stock has a 50 day moving average of $68.40 and a two-hundred day moving average of $56.42. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $75.41.

Ralliant (NYSE:RAL) last announced its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts forecast that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio is presently -1.84%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Evercore assumed coverage on Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective for the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. Royal Bank Of Canada boosted their price target on shares of Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a report on Friday, July 31st. Oppenheimer increased their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Finally, Barclays raised their price objective on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a report on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Ralliant has an average rating of “Moderate Buy” and a consensus price target of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.